中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [15]
合肥物质科学研究院 [10]
广州生物医药与健康研... [5]
采集方式
OAI收割 [30]
内容类型
期刊论文 [30]
发表日期
2024 [1]
2023 [1]
2022 [2]
2021 [4]
2020 [1]
2019 [1]
更多
学科主题
Chemistry [2]
Pharmacolo... [2]
筛选
浏览/检索结果:
共30条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor
期刊论文
OAI收割
BIOORGANIC CHEMISTRY, 2024, 卷号: 143, 页码: 16
作者:
Sun, Yaoliang
;
Chen, Zhiwen
;
Liu, Guobin
;
Chen, Xiaoai
;
Shi, Zihan
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2024/03/25
Inhibitor
Cancer
Threonine tyrosine kinase (TTK)
Covalent
Covalent Binding Mechanism of Furmonertinib and Osimertinib With Human Serum AlbuminS
期刊论文
OAI收割
DRUG METABOLISM AND DISPOSITION, 2023, 卷号: 51, 期号: 1, 页码: 8-16
作者:
Wu, Yali
;
Chen, Lili
;
Chen, Jian
;
Xue, Hao
;
He, Qingfeng
  |  
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2024/03/27
Triazine-Based Covalent DNA-Encoded Libraries for Discovery of Covalent Inhibitors of Target Proteins
期刊论文
OAI收割
ACS MEDICINAL CHEMISTRY LETTERS, 2022, 页码: 8
作者:
Li, Linjie
;
Su, Mingbo
;
Lu, Weiwei
;
Song, Hongzhi
;
Liu, Jiaxiang
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2022/09/30
DNA encoded library
covalent library
library design
covalent inhibitors
Discovery of Pteridine-7(8H)-one Derivatives as Potent and Selective Inhibitors of Bruton's Tyrosine Kinase (BTK)
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 3, 页码: 2694-2709
作者:
Dou, Dou
;
Diao, Yanyan
;
Sha, Wenjie
;
Su, Rongrong
;
Tong, Linjiang
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2022/08/16
Discover Novel Covalent Inhibitors Targeting FLT3 through Hybrid Virtual Screening Strategy
期刊论文
OAI收割
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 卷号: 44, 期号: 12, 页码: 1872-1877
作者:
Hu, Shengquan
;
Liu, Jing
;
Chen, Sikang
;
Gao, Jian
;
Zhou, Yubo
  |  
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/06/15
acute myeloid leukemia
FMS-like tyrosine kinase 3
CovDock
hybrid virtual screening
autodock
Discovery of a potent, selective, and covalent ZAP-70 kinase inhibitor
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 219, 页码: 12
作者:
Rao, Danni
;
Li, Heng
;
Ren, Xuelian
;
Sun, Yaoliang
;
Wen, Cuiyun
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2021/08/17
Zeta-chain associated protein kinase 70 kDa (ZAP-70)
Covalent inhibitor
T cell
Autoimmune diseases
Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2021, 卷号: 11, 期号: 3, 页码: 781-794
作者:
Wu, Xiaowei
;
Dai, Mengdi
;
Cui, Rongrong
;
Wang, Yulan
;
Li, Chunpu
  |  
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2021/05/24
Tyrosine kinase
Covalent FGFR inhibitors
Virtual screening
Pyrazolo[3,4-d] pyridazinone
Structure-activity relationships
Antitumor efficacy
p Metabolite Identification in the Preclinical and Clinical Phase of Drug Development
期刊论文
OAI收割
CURRENT DRUG METABOLISM, 2021, 卷号: 22, 期号: 11, 页码: 838-857
作者:
Wu, Yali
;
Pan, Lulu
;
Chen, Zhendong
;
Zheng, Yuandong
;
Diao, Xingxing
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2022/06/15
Metabolite identification
drug toxicity
drug exposure
covalent-binding drug
drug safety
natural medicines
Characterization of covalent binding of tyrosine kinase inhibitors to plasma proteins
期刊论文
OAI收割
DRUG METABOLISM AND PHARMACOKINETICS, 2020, 卷号: 35, 期号: 5, 页码: 456-465
作者:
Liu, Xiaoyun
;
Feng, Dan
;
Zheng, Mingyue
;
Cui, Yongmei
;
Zhong, Dafang
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/12/21
Covalent tyrosine kinase inhibitors
Covalent binding
Human serum albumin
Molecular docking
Quantitative calculations
Linear modeling
Species difference
Design, synthesis and biological study of potent and covalent HER-2 tyrosine kinase inhibitors with low cytotoxicity in vitro
期刊论文
OAI收割
CHEMICAL PAPERS, 2019, 卷号: 73, 期号: 6, 页码: 1333-1345
作者:
Jin, Shuyu
;
Sun, Xiuyun
;
Liu, Dan
;
Xie, Hua
;
Rao, Yu
  |  
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2020/07/01
HER-2 inhibitors
4-Anilino-3-cyanoquinoline
Covalent
Anticancer activity